JORGE EMILIO
ORTEGA CALVO
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (12)
2023
-
Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring
Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
2022
2021
-
Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
Frontiers in Pharmacology, Vol. 12
2019
2018
-
Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram
Neuropharmacology, Vol. 133, pp. 491-502
2017
-
Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain
Neuropharmacology, Vol. 114, pp. 114
2016
-
Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study
Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867
2014
-
Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain
Journal of Neuroinflammation, Vol. 11, Núm. 1
2013
-
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19
-
Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: A microdialysis study in rat brain
Psychopharmacology, Vol. 229, Núm. 2, pp. 331-344
2008
-
CEREBRAL MICRODIALYSIS IN CLINICAL PRACTICE: CHEMICAL MARKERS IN A MODEL FOR ACUTE FOCAL ISCHEMIA IN THE HUMAN BRAIN
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY